ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Dr Reddys Laboratories Ltd

Dr Reddys Laboratories Ltd (RDY)

14,38
0,39
(2,79%)
Geschlossen 06 Juli 10:00PM
14,39
0,01
(0,07%)
Nach Börsenschluss: 1:59AM

Dr Reddys Laboratories Ltd (RDY) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
14,38
( 2,79% )
Gebot
-
Fragen
-
Volumen
2.176.391
14,16 Tagesbereich 14,485
12,185 52-Wochen-Bereich 15,67
Marktkapitalisierung
Handelsende
13,99
Handelsbeginn
14,16
Letzte Trade
254108
@
14.38
Letzter Handelszeitpunkt
Finanzvolumen
US$ 31.190.854
VWAP
14,3315
Durchschnittliches Volumen (3 Mio.)
US$ 99.857
Ausgegebene Aktien
832.691.395
Dividendenrendite (LTM)
8 (0,63%)
Kurs-Gewinn-Verhältnis
26,05
Gewinn pro Aktie (EPS)
51,42
Erlöse (LTM)
335,93B
Nettogewinn (LTM)
42,85B

Über Dr Reddys Laboratories Ltd

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its G... Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. Its Others segment engages in developing therapies in the fields of oncology and inflammation; and research, development, and commercialization of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines, vitamins and minerals, and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. Mehr anzeigen

Sektor
Healthcare
Branche
Pharmaceuticals
Hauptsitz
Hyderabad, India
Gegründet
1984
Dr Reddys Laboratories Ltd is listed in the Healthcare sector of the New York Börse with ticker RDY. The last closing price for Dr Reddys Laboratories was US$13,99. Over the last year, Dr Reddys Laboratories shares have traded in a share price range of US$ 12,185 to US$ 15,67.

Dr Reddys Laboratories currently has 832.691.395 shares in issue. The market capitalisation of Dr Reddys Laboratories is US$11,97 billion. Dr Reddys Laboratories has a price to earnings ratio (PE ratio) of 26.05.

RDY Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.28-1.9099590723114.6615.6713.95410700914.83003357CS
41.188.9393939393913.215.6713.08255765114.17909678CS
121.18.2831325301213.2815.6712.185257489913.60341619CS
260.473.3788641265313.9115.6712.185229406513.72230509CS
52-0.52-3.4899328859114.915.6712.185170532913.87710568CS
156-48.36-77.08001275162.7484.4612.185106921719.66177805CS
260-60.87-80.890365448575.2584.4612.18571568023.54411083CS

RDY - Frequently Asked Questions (FAQ)

What is the current Dr Reddys Laboratories Ltd share price?
The current share price of Dr Reddys Laboratories Ltd is US$ 14,38
How many Dr Reddys Laboratories Ltd shares are in issue?
Dr Reddys Laboratories Ltd has 832.691.395 shares in issue
What is the market cap of Dr Reddys Laboratories Ltd?
The market capitalisation of Dr Reddys Laboratories Ltd is USD 11,97B
What is the 1 year trading range for Dr Reddys Laboratories Ltd share price?
Dr Reddys Laboratories Ltd has traded in the range of US$ 12,185 to US$ 15,67 during the past year
What is the PE ratio of Dr Reddys Laboratories Ltd?
The price to earnings ratio of Dr Reddys Laboratories Ltd is 26,05
What is the cash to sales ratio of Dr Reddys Laboratories Ltd?
The cash to sales ratio of Dr Reddys Laboratories Ltd is 3,32
What is the registered address of Dr Reddys Laboratories Ltd?
The registered address for Dr Reddys Laboratories Ltd is 8-2-337, Road No. 3, Hyderabad, 500034
What is the Dr Reddys Laboratories Ltd website address?
The website address for Dr Reddys Laboratories Ltd is www.drreddys.com
Which industry sector does Dr Reddys Laboratories Ltd operate in?
Dr Reddys Laboratories Ltd operates in the Pharmaceuticals sector

RDY Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen